Reduction of the content of protein contaminants in compositions comprising a Vitamin K-dependent protein of interest

Details for Australian Patent Application No. 2005318106 (hide)

Owner Novo Nordisk Health Care AG

Inventors Rasmussen, Daniel E.; Hansen, Thomas Budde; Staby, Arne; Bang, Susanne; Bogsnes, Are; Ahmadian, Haleh; Krarup, Janus; Arentsen, Anne Charlotte

Agent Shelston IP

Pub. Number AU-B-2005318106

PCT Pub. Number WO2006/067230

Priority PA 2004 02008 23.12.04 DK

Filing date 23 December 2005

Wipo publication date 29 June 2006

Acceptance publication date 3 November 2011

International Classifications

C07K 1/16 (2006.01) General processes for the preparation of peptides

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/067230 Priority application(s): WO2006/067230

3 November 2011 Application Accepted

  Published as AU-B-2005318106

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005318107-Process for the preparation of alkylene glycols wherein a guard bed is used before the catalyst bed

2005318097-Michael-type addition reaction functionalised peg hydrogels with factor XIIIA incorporated biofactors